CCOc1cccc(OCC)c2c(C)[n+](CC3CCCO3)c(C)c1-2.[O-][Cl+3]([O-])([O-])[O-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?